English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Aduro Biotech
Jamie Barrand
| Nov 25, 2015
CRS-207 designated as orphan drug for mesothelioma treatment
Trending
+
Pharmaceuticals
Patient Daily
| Sep 12, 2025
Taxpayers Protection Alliance says 340B program is driving up taxpayer costs
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
Patient Daily
| Sep 15, 2025
Physician assistant on sinus issues and sleep disruption: ‘Any kind of sinus issue will always affect your sleep’
